Technology News and Research

RSS

Information technology can improve TB screening, treatment programs

In a Center for Health Market Innovations blog post, Arjun Vasan of the Results for Development Institute uses preliminary research and analysis data collected by CHMI and the University of Toronto to examine "innovative ways to improve privately delivered TB care."

4 Apr 2013

Tris Pharma gets FDA NDA approval for Karbinal ER Extended-release Oral Suspension

Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.

4 Apr 2013

Clinical trial signals new era in treatment of neurodegererative disorders

The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis - blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease - may be a first step towards a new era in the treatment of such disorders.

4 Apr 2013

Lund University researchers examine why people suffer vision loss in eye diseases

Using new technology and new approaches, researchers at Lund University in Sweden hope to be able to explain why people suffer vision loss in eye diseases such as retinal detachment and glaucoma.

4 Apr 2013

Article describes Brain Activity Mapping could bring new understanding of how brain works

The scientific tools are not yet available to build a comprehensive map of the activity in the most complicated 3 pounds of material in the world - the human brain, scientists say in a newly published article.

4 Apr 2013

Researchers discover injectable protein to reverse symptoms of dangerous conditions

The creation of new blood vessels in the body, called "angiogenesis," is usually discussed in connection with healing wounds and tumors. But it's also an ongoing process in the female reproductive tract, where the growth and breaking of blood vessels is a normal part of the menstrual cycle. But abnormal growth of blood vessels can have painful consequences and resultant pathologies.

4 Apr 2013

AngioDynamics supports SIRF's Discovery Campaign to expand minimally invasive medicine

The Society of Interventional Radiology Foundation's Discovery campaign will benefit from a $500,000 pledge by new "Futurist" level supporter, medical device manufacturer AngioDynamics.

3 Apr 2013

A new method to kill pathogenic bacteria

Engineering researchers at Rensselaer Polytechnic Institute have developed a new method to kill deadly pathogenic bacteria, including listeria, in food handling and packaging. This innovation represents an alternative to the use of antibiotics or chemical decontamination in food supply systems.

3 Apr 2013

New medical device detects biothreat agents

Researchers at Sandia National Laboratories are developing a medical instrument that will be able to quickly detect a suite of biothreat agents, including anthrax, ricin, botulinum, shiga and SEB toxin.

3 Apr 2013

FDA clears LENSAR Laser System to perform corneal, arcuate incisions during cataract surgery

LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration for the execution of arcuate incisions during cataract surgery.

3 Apr 2013

Oramed Pharmaceuticals receives Japanese patent for innovative oral delivery technology

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it has received approval for a key patent by the Japanese Patent Office.

3 Apr 2013

Life-changing ChromaGen lenses for people with dyslexia, other reading disorders

Words that move from left to right or up and down, words that are blurry or come in and out of focus or words that appear to float on the page, seeing double words or double sentences, re-reading the same lines - these are some of the reading difficulties that students everywhere are struggling with.

3 Apr 2013

UAB School of Nursing offers health care services in rural communities

"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.

3 Apr 2013

Mazor Robotics enters into agreement with major U.S. hospital for four Renaissance systems

Mazor Robotics Ltd., the developer of Renaissance, an innovative surgical guidance system and its complementary products, today announced that on March 28, 2013, it entered into an agreement for the acquisition of four Renaissance systems by a major U.S. hospital corporation.

3 Apr 2013

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins, announced today that it has entered into a global collaboration agreement with Pfizer Inc. to develop and commercialize Accurins utilizing select small molecule targeted therapies.

3 Apr 2013

Washington Post examines how mobile technologies are transforming remote parts of Africa

The Washington Post examines how new mobile applications are transforming remote parts of Africa.

3 Apr 2013

Sanford-Burnham selects organizations to participate in Florida Translational Research Program

Sanford-Burnham Medical Research Institute at Lake Nona announced the selection of the first five research organizations that will participate in the Florida Translational Research Program to advance drug discovery in the state.

3 Apr 2013

Kavli Foundation applauds launch of new brain research initiative

The Kavli Foundation applauds today's launch by President Obama of his Administration's ambitious research effort to understand the brain by deciphering the brain's activity that gives rise to our perceptions, our experiences and our consciousness.

3 Apr 2013

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has dosed the first patient in its second Phase 2 clinical study with LiRIS, its novel product candidate, in patients with Interstitial Cystitis.

3 Apr 2013

Image sharing aims to reduce need for repeat scans

Several state and regional health-information exchanges have begun sharing images electronically, and a number of companies sell image-sharing technology directly to hospitals and radiology clinics in a development that could slow health care spending.

3 Apr 2013

Technology News and Research

Information technology can improve TB screening, treatment programs

Tris Pharma gets FDA NDA approval for Karbinal ER Extended-release Oral Suspension

Clinical trial signals new era in treatment of neurodegererative disorders

Lund University researchers examine why people suffer vision loss in eye diseases

Article describes Brain Activity Mapping could bring new understanding of how brain works

Researchers discover injectable protein to reverse symptoms of dangerous conditions

AngioDynamics supports SIRF's Discovery Campaign to expand minimally invasive medicine

A new method to kill pathogenic bacteria

New medical device detects biothreat agents

FDA clears LENSAR Laser System to perform corneal, arcuate incisions during cataract surgery

Oramed Pharmaceuticals receives Japanese patent for innovative oral delivery technology

Life-changing ChromaGen lenses for people with dyslexia, other reading disorders

UAB School of Nursing offers health care services in rural communities

Mazor Robotics enters into agreement with major U.S. hospital for four Renaissance systems

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

Washington Post examines how mobile technologies are transforming remote parts of Africa

Sanford-Burnham selects organizations to participate in Florida Translational Research Program

Kavli Foundation applauds launch of new brain research initiative

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

Image sharing aims to reduce need for repeat scans

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News